Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

MammoWave · Cutting edge microwave imaging device for safe and accurate breast cancer screening

H2020Status: CLOSED1 October 201831 August 2021EU funding €1,393,114Call H2020-EIC-SMEInst-2018-2020

Breast cancer (BC) is the most prevalent form of cancer in women. One in nine women will acquire BC at some point in their life and one in thirty will die from the disease . Most EU countries have adopted mass BC screening programmes as a way for detecting the disease early, using tools such as mammography machines. Mammography has been the medical industry’s “gold standard” breast cancer screening tool for nearly four decades. However, a number of adverse effects, backed up by mounting scientific evidence, are now limiting the use of mammography as a mass screening device.MammoWave is a revolutionary BC screening device for highly accurate cancer detection based on safe microwaves instead of ionizing radiation (X-rays). The excellent overall sensitivity (ongoing clinical trials show sensitivity above 90%), the simple method that requires no squishing of the breast, and the complete safety of the microwave imaging technique, make MammoWave primed for mass BC screening.

Consortium · 1 organisation

coordinator

UMBRIA BIOENGINEERING TECNOLOGIES SOCIETA A RESPONSABILITA LIMITATA

IT · €1,393,114

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.